Log in | Register

Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century

Jordi Rello| Bárbara Borgatta| Thiago Lisboa
What's New in Intensive Care
Volume 39, Issue 12 / December , 2013

Pages 2204 - 2206

No abstract available.

References

  1. Vincent JL, Rello J, Marshall J, Silva C, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infections in intensive care units. JAMA 302:2323–2329
    • View reference on PubMed
    • View reference on publisher's website
  2. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D’Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2013) Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 39(4):682–692
  3. Rello J, Jubert P, Valles J, Artigas A, Rué M, Niederman MS (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978
    • View reference on PubMed
    • View reference on publisher's website
  4. Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, Prats G (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20:193–198
  5. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J (2007) Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35:1888–1895
    • View reference on PubMed
    • View reference on publisher's website
  6. Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP (2011) Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 37:632–638
  7. Venier AG, Gruson D, Lavigne T, Jarno P, L’Hériteau F, Coignard B, Savey A, Rogues AM, REA-RAISIN group (2011) Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN. J Hosp Infect 79:44–48
    • View reference on PubMed
    • View reference on publisher's website
  8. Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, Agbaht K, Pobo A, Diaz E (2006) Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology 105:709–714
    • View reference on PubMed
    • View reference on publisher's website
  9. Leroy O, D’Escriban T, Devos P, Dubreuil L, Kipnis E, Georges H (2005) Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Infection 33:129–135
    • View reference on PubMed
    • View reference on publisher's website
  10. Bonten MJM, Kollef MH, Hall JB (2004) Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 38:1141–1149
    • View reference on PubMed
    • View reference on publisher's website
  11. Rello J, Ulldemolins M, Lisboa T, Koulenti D, Mañez R, Martin-Loeches I, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37:1332–1339
    • View reference on PubMed
    • View reference on publisher's website
  12. Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Mañez R, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681
  13. Leroy O, Jaffré S, D’Escrivan T, Devos P, Georges H, Alfandari S, Beaucaire G (2003) Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients. Chest 123:2034–2042
    • View reference on PubMed
    • View reference on publisher's website
  14. Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, Brown R, Hugenholtz P, DeSantis TZ, Andersen GL, Wiener-Kronish JP, Bristow J (2007) Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 45:1954–1962
    • View reference on PubMed
    • View reference on publisher's website
  15. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gilbert C (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34:1047–1054
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement